国际眼科杂志Issue(12)：2168-2171,4.DOI:10.3980/j.issn.1672-5123.2014.12.16
新生淋巴管与角膜移植排斥的研究进展
Research advances in corneal newborn lymphatic vessel and corneal transplantation rejection
麦洁英 1唐先玲 1刘平1
作者信息
- 1. 150001 中国黑龙江省哈尔滨市，哈尔滨医科大学第一附属医院眼科医院
- 折叠
摘要
Abstract
Corneal newborn lymphatic vessels construct the afferent arc of corneal immunological reaction, which play important role in immune response. The corneal transplantation rejection rate rises due to the emergence of new lymphatic vessel which breaks the immunologic mechanism. With the founding of specific marker of lymphatic endothelial cells and research advancing of growth factor of lymphatic vessels, the mechanism, therapy and prevention of corneal immunological rejection reaction of corneal lymphatic vessel have been studied intensively. The graft survival rate has been greatly improved through inhibiting newborn lymphatic vessel.关键词
角膜新生淋巴管/角膜移植排斥/免疫赦免Key words
corneal newborn lymphatic vessel/neal transplantation rejection/immune privilege引用本文复制引用
麦洁英,唐先玲,刘平..新生淋巴管与角膜移植排斥的研究进展[J].国际眼科杂志,2014,(12):2168-2171,4.
